doi: 10.1001/jama.1946.02870240008003.
Prostatic cancer treated by orchiectomy; the five year results
- PMID: 20986021
- DOI: 10.1001/jama.1946.02870240008003
Item in Clipboard
Prostatic cancer treated by orchiectomy; the five year results
J Am Med Assoc.
.
No abstract available
Similar articles
-
Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.J Urol. 2017 Jul;198(1):86-91. doi: 10.1016/j.juro.2017.01.063. Epub 2017 Jan 24. J Urol. 2017. PMID: 28130104
-
Orchiectomy and delayed radiotherapy as treatment for prostatic carcinoma. A 10-year survey.Br J Urol. 1986 Aug;58(4):417-22. doi: 10.1111/j.1464-410x.1986.tb09096.x. Br J Urol. 1986. PMID: 3756411
-
Long-term results of Danish Prostatic Cancer Group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer.Cancer. 1993 Dec 15;72(12 Suppl):3851-4. doi: 10.1002/1097-0142(19931215)72:12+<3851::aid-cncr2820721717>3.0.co;2-x. Cancer. 1993. PMID: 8252502 Clinical Trial.
-
Bilateral orchiectomy in the management of stage D-2 prostate cancer.Int Surg. 1993 Jan-Mar;78(1):73-5. Int Surg. 1993. PMID: 8473090
-
Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective prostatic cancer study.Br J Urol. 1986 Oct;58(5):528-33. doi: 10.1111/j.1464-410x.1986.tb05461.x. Br J Urol. 1986. PMID: 3779355
Cited by
-
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer.Cell Rep Med. 2022 Mar 15;3(3):100561. doi: 10.1016/j.xcrm.2022.100561. eCollection 2022 Mar 15. Cell Rep Med. 2022. PMID: 35492874 Free PMC article.
-
TRIM33 loss reduces androgen receptor transcriptional output and H2BK120 ubiquitination.Commun Biol. 2025 Jul 11;8(1):1043. doi: 10.1038/s42003-025-08449-2. Commun Biol. 2025. PMID: 40646276 Free PMC article.
-
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.Oncogene. 2013 Dec 5;32(49):5501-11. doi: 10.1038/onc.2013.206. Epub 2013 Jun 10. Oncogene. 2013. PMID: 23752182 Free PMC article. Review.
-
Advancing precision medicine for prostate cancer through genomics.J Clin Oncol. 2013 May 20;31(15):1866-73. doi: 10.1200/JCO.2012.45.3662. Epub 2013 Apr 15. J Clin Oncol. 2013. PMID: 23589550 Free PMC article. Review.
-
Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's Perspective.Cancer Manag Res. 2022 Aug 8;14:2389-2397. doi: 10.2147/CMAR.S326114. eCollection 2022. Cancer Manag Res. 2022. PMID: 35967752 Free PMC article. Review.